Comparative Pharmacology
Head-to-head clinical analysis: NORGESTREL AND ETHINYL ESTRADIOL versus PREMPHASE 14 14.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NORGESTREL AND ETHINYL ESTRADIOL versus PREMPHASE 14 14.
NORGESTREL AND ETHINYL ESTRADIOL vs PREMPHASE 14/14
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Norgestrel is a progestogen that suppresses gonadotropin secretion, primarily LH, inhibiting ovulation and altering cervical mucus to impede sperm penetration. Ethinyl estradiol is an estrogen that stabilizes the endometrium and provides negative feedback on gonadotropin release, contributing to contraceptive efficacy.
Conjugated estrogens (CE) bind to estrogen receptors (ERα and ERβ), modulating gene transcription and non-genomic signaling pathways to induce estrogenic effects. Medroxyprogesterone acetate (MPA) is a progestin that binds to progesterone receptors, suppressing endometrial proliferation and counteracting estrogen-induced endometrial hyperplasia. The combination provides hormone replacement therapy with reduced risk of endometrial cancer.
One tablet (0.3 mg norgestrel/0.03 mg ethinyl estradiol) orally once daily, taken at the same time each day.
One tablet orally once daily, each tablet contains conjugated estrogens 0.625 mg and medroxyprogesterone acetate 5 mg.
None Documented
None Documented
Norgestrel: terminal half-life ~45 hours (range 24–50 h), supporting once-daily dosing; Ethinyl estradiol: terminal half-life ~17 hours (range 10–24 h).
Conjugated estrogens have a terminal elimination half-life of 12-24 hours for conjugated equine estrogens; medroxyprogesterone acetate has a half-life of 12-17 hours. Steady-state is reached within 5-7 days.
Norgestrel: 45% renal, 32% fecal as metabolites; Ethinyl estradiol: 40% renal, 60% fecal as glucuronide and sulfate conjugates.
Conjugated estrogens are excreted primarily in urine (≥90%) as glucuronide and sulfate conjugates; medroxyprogesterone acetate is extensively metabolized and excreted in urine (≤60%) and feces (≤30%) as metabolites.
Category D/X
Category C
Estrogen
Estrogen/Progestin Combination